• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血小板在肿瘤血管生成中的作用。

The role of blood platelets in tumor angiogenesis.

作者信息

Sabrkhany Siamack, Griffioen Arjan W, Oude Egbrink Mirjam G A

机构信息

Laboratory for Microcirculation, Cardiovascular Research Institute Maastricht (CARIM), Dept. of Physiology, Maastricht, The Netherlands.

出版信息

Biochim Biophys Acta. 2011 Apr;1815(2):189-96. doi: 10.1016/j.bbcan.2010.12.001. Epub 2010 Dec 16.

DOI:10.1016/j.bbcan.2010.12.001
PMID:21167916
Abstract

Coagulation abnormalities occur frequently in cancer patients. It is becoming evident that blood platelets have an important function in this process. However, understanding of the underlying mechanisms is still very modest. In this review, we discuss the role of platelets in tumor angiogenesis and growth and suggest their potential significance in malignancies. Platelets contain various pro-and antiangiogenic molecules, which seem to be endocytosed and sequestered in different populations of α-granules. Furthermore, tumor endothelial cells are phenotypically and functionally different from endothelial cells in healthy tissue, stimulating local platelet adhesion and subsequent activation. As a consequence, platelets are able to secrete their angiogenic and angiostatic content, most likely in a regulated manner. The overall effect of these platelet-endothelium interactions appears to be proangiogenic, stimulating tumor angiogenesis. We favor the view that local adhesion and activation of blood platelets and dysregulation of coagulation represent underestimated pathways in the progression of cancer.

摘要

凝血异常在癌症患者中经常出现。越来越明显的是,血小板在这一过程中具有重要作用。然而,对其潜在机制的了解仍然非常有限。在这篇综述中,我们讨论了血小板在肿瘤血管生成和生长中的作用,并提出它们在恶性肿瘤中的潜在意义。血小板含有各种促血管生成和抗血管生成分子,这些分子似乎被内吞并隔离在不同群体的α颗粒中。此外,肿瘤内皮细胞在表型和功能上与健康组织中的内皮细胞不同,会刺激局部血小板黏附并随后激活。因此,血小板能够以一种很可能是受调控的方式分泌其血管生成和血管抑制成分。这些血小板-内皮细胞相互作用的总体效果似乎是促血管生成的,刺激肿瘤血管生成。我们赞同这样一种观点,即血小板的局部黏附与激活以及凝血失调是癌症进展中被低估的途径。

相似文献

1
The role of blood platelets in tumor angiogenesis.血小板在肿瘤血管生成中的作用。
Biochim Biophys Acta. 2011 Apr;1815(2):189-96. doi: 10.1016/j.bbcan.2010.12.001. Epub 2010 Dec 16.
2
The functional role of platelets in the regulation of angiogenesis.血小板在血管生成调节中的功能作用。
Platelets. 2015;26(3):199-211. doi: 10.3109/09537104.2014.909022. Epub 2014 May 15.
3
Platelets and angiogenesis in malignancy.恶性肿瘤中的血小板与血管生成
Semin Thromb Hemost. 2004 Feb;30(1):95-108. doi: 10.1055/s-2004-822974.
4
The functional role of blood platelet components in angiogenesis.血小板成分在血管生成中的功能作用。
Thromb Haemost. 2004 Aug;92(2):394-402. doi: 10.1160/TH03-04-0213.
5
A novel role for platelet secretion in angiogenesis: mediating bone marrow-derived cell mobilization and homing.血小板分泌在血管生成中的新作用:介导骨髓来源细胞的动员和归巢。
Blood. 2011 Apr 7;117(14):3893-902. doi: 10.1182/blood-2010-08-304808. Epub 2011 Jan 11.
6
Platelets and cancer angiogenesis nexus.血小板与癌症血管生成的关系
Cancer Metastasis Rev. 2017 Jun;36(2):249-262. doi: 10.1007/s10555-017-9673-1.
7
[Role of platelet in angiogenesis].[血小板在血管生成中的作用]
Zhejiang Da Xue Xue Bao Yi Xue Ban. 2009 Jul;38(4):427-32.
8
Involvement of platelets in tumour angiogenesis?血小板参与肿瘤血管生成?
Lancet. 1998 Nov 28;352(9142):1775-7. doi: 10.1016/s0140-6736(98)05095-8.
9
The effect of P2Y-mediated platelet activation on the release of VEGF and endostatin from platelets.P2Y 介导的血小板激活对血小板释放 VEGF 和内皮抑素的影响。
Platelets. 2010;21(2):85-93. doi: 10.3109/09537100903470298.
10
Platelets and cancer: implications for antiangiogenic therapy.血小板与癌症:抗血管生成疗法的意义
Semin Thromb Hemost. 2002 Feb;28(1):39-44. doi: 10.1055/s-2002-20563.

引用本文的文献

1
Platelets in Hepatocellular Carcinoma-From Pathogenesis to Targeted Therapy.肝细胞癌中的血小板——从发病机制到靶向治疗
Cancers (Basel). 2025 Jul 18;17(14):2391. doi: 10.3390/cancers17142391.
2
Role of Liquid Biopsy for Early Detection, Prognosis, and Therapeutic Monitoring of Hepatocellular Carcinoma.液体活检在肝细胞癌早期检测、预后评估及治疗监测中的作用
Diagnostics (Basel). 2025 Jun 28;15(13):1655. doi: 10.3390/diagnostics15131655.
3
Tumor-Educated Platelets in Urological Tumors: A Novel Biosource in Liquid Biopsy.泌尿系统肿瘤中的肿瘤衍生血小板:液体活检中的新型生物来源
Int J Mol Sci. 2025 Apr 11;26(8):3595. doi: 10.3390/ijms26083595.
4
Baseline and changes in inflammatory parameters for patients with EGFR-mutated NSCLC treated with afatinib.接受阿法替尼治疗的表皮生长因子受体(EGFR)突变的非小细胞肺癌(NSCLC)患者的基线炎症参数及变化
Thorac Cancer. 2025 Jul;16(13):e15338. doi: 10.1111/1759-7714.15338. Epub 2025 Apr 17.
5
Use of consensus clustering to identify subtypes of clinical early-stage non-small cell lung cancer and its association with lymph node metastasis.使用共识聚类法识别临床早期非小细胞肺癌的亚型及其与淋巴结转移的关系。
Discov Oncol. 2025 Apr 16;16(1):536. doi: 10.1007/s12672-025-02148-4.
6
Bidirectional relationship between platelet count and skin cancer: tumor drug resistance mechanisms.血小板计数与皮肤癌之间的双向关系:肿瘤耐药机制
Discov Oncol. 2025 Mar 19;16(1):361. doi: 10.1007/s12672-025-02122-0.
7
Clinical implications of the serum platelet-to-lymphocyte ratio in the modern radiation oncology era: research update and literature review.血清血小板与淋巴细胞比值在现代放射肿瘤学时代的临床意义:研究更新与文献回顾。
Radiat Oncol. 2024 Aug 13;19(1):107. doi: 10.1186/s13014-024-02485-8.
8
Platelet-Rich Plasma (PRP) for Endometrial Treatment Efficacy and Safety in Assisted Reproductive Technology: A Comprehensive Review.富血小板血浆(PRP)用于辅助生殖技术中子宫内膜治疗的疗效与安全性:一项综述
Cureus. 2024 May 6;16(5):e59728. doi: 10.7759/cureus.59728. eCollection 2024 May.
9
Development and Validation of a Prognostic Nomogram for HR+ HER- Breast Cancer.HR+ HER- 乳腺癌预后列线图的开发与验证
Cancer Manag Res. 2024 May 21;16:491-505. doi: 10.2147/CMAR.S459714. eCollection 2024.
10
Clinical Utility of Cytokeratins for Accurate Diagnosis of Hepatocellular Carcinoma Among Hepatitis C Virus High-Risk Patients.在丙型肝炎病毒高危患者中,细胞角蛋白对准确诊断肝细胞癌的临床实用性。
Asian Pac J Cancer Prev. 2024 Apr 1;25(4):1325-1332. doi: 10.31557/APJCP.2024.25.4.1325.